Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HYPERTENSION DRUGS INDUSTRY
2.1 Summary about Hypertension Drugs Industry
2.2 Hypertension Drugs Market Trends
2.2.1 Hypertension Drugs Production & Consumption Trends
2.2.2 Hypertension Drugs Demand Structure Trends
2.3 Hypertension Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Systemic hypertension drugs
4.2.2 Pulmonary hypertension drugs
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Drugstore
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Systemic hypertension drugs
5.2.2 Pulmonary hypertension drugs
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Drugstore
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Systemic hypertension drugs
6.2.2 Pulmonary hypertension drugs
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Drugstore
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Systemic hypertension drugs
7.2.2 Pulmonary hypertension drugs
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Drugstore
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Systemic hypertension drugs
8.2.2 Pulmonary hypertension drugs
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Drugstore
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Systemic hypertension drugs
9.2.2 Pulmonary hypertension drugs
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Drugstore
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novartis
10.1.2 Daiichi Sankyo
10.1.3 Actelion Pharmaceuticals
10.1.4 Boehringer Ingelheim
10.1.5 Sanofi
10.1.6 Pfizer
10.1.7 Actelion Pharmaceuticals
10.1.8 Bayer
10.1.9 Johnson & Johnson
10.1.10 Merck
10.2 Hypertension Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Novartis
10.2.2 Daiichi Sankyo
10.2.3 Actelion Pharmaceuticals
10.2.4 Boehringer Ingelheim
10.2.5 Sanofi
10.2.6 Pfizer
10.2.7 Actelion Pharmaceuticals
10.2.8 Bayer
10.2.9 Johnson & Johnson
10.2.10 Merck
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Hypertension Drugs Product Type Overview
Table Hypertension Drugs Product Type Market Share List
Table Hypertension Drugs Product Type of Major Players
Table Brief Introduction of Novartis
Table Brief Introduction of Daiichi Sankyo
Table Brief Introduction of Actelion Pharmaceuticals
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of Sanofi
Table Brief Introduction of Pfizer
Table Brief Introduction of Actelion Pharmaceuticals
Table Brief Introduction of Bayer
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Merck
Table Products & Services of Novartis
Table Products & Services of Daiichi Sankyo
Table Products & Services of Actelion Pharmaceuticals
Table Products & Services of Boehringer Ingelheim
Table Products & Services of Sanofi
Table Products & Services of Pfizer
Table Products & Services of Actelion Pharmaceuticals
Table Products & Services of Bayer
Table Products & Services of Johnson & Johnson
Table Products & Services of Merck
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Hypertension Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Hypertension Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Hypertension Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Hypertension Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f